Warner Chilcott Licenses Psoriasis Drug
This article was originally published in The Pink Sheet Daily
Warner Chilcott has agreed to license Dovobet from LEO Pharma S/A upon FDA approval
You may also be interested in...
Psoriasis salve lifts first-quarter revenue, ahead of $40 million milestone payout to Denmark firm Leo Pharma.
Italy claims to have pushed farther into managed entry agreements than other European countries with strong clawback provisions on new drugs – particularly cancer drugs – if they don't work as well as their manufacturers claim. The financial clawbacks are supported by extensive outcome data collection across the country's twenty regions.